Gros David-Alexandre C
SEC insider (Form 3/4/5 filer). CIK 0001644489. Chief Executive Officer at Eledon Pharmaceuticals, Inc. (ELDN). 5 reported Form 4/5 transactions since Sep 2024; latest on Jul 31, 2026. Located in IRVINE, CA.
Companies Gros David-Alexandre C has filed insider reports for
- Eledon Pharmaceuticals, Inc. (ELDN): Director, Officer, Chief Executive Officer
Gros David-Alexandre C
CIK: 0001644489
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Eledon Pharmaceuticals, Inc.
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Jul 31, 2026ELDN
Eledon Pharmaceuticals, Inc.
AwardDirect354.5K shares- - Jul 31, 2026ELDN
Eledon Pharmaceuticals, Inc.
Tax PaymentDirect194.8K shares at avg. $3.38$658K - Jan 10, 2025ELDN
Eledon Pharmaceuticals, Inc.
AwardDirectStock Option (right to buy)
600K shares- - Jan 10, 2025ELDN
Eledon Pharmaceuticals, Inc.
AwardDirectRestricted Stock Units
66.5K shares- - Nov 21, 2024ELDN
Eledon Pharmaceuticals, Inc.
AwardDirectStock Option (right to buy)
1M shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 31, 2026 | ELDN Eledon Pharmaceuticals, Inc. | Award | 354,454 | - | $0 | Direct |
| Jul 31, 2026 | ELDN Eledon Pharmaceuticals, Inc. | Tax Payment | 194,791 | $3.38 | $658,394 | Direct |
| Jan 10, 2025 | ELDN Eledon Pharmaceuticals, Inc. | Award Stock Option (right to buy) | 600,000 | - | - | Direct |
| Jan 10, 2025 | ELDN Eledon Pharmaceuticals, Inc. | Award Restricted Stock Units | 66,500 | - | - | Direct |
| Nov 21, 2024 | ELDN Eledon Pharmaceuticals, Inc. | Award Stock Option (right to buy) | 1,015,743 | - | - | Direct |
1-5 of 5 transactions